Skip to main content
. Author manuscript; available in PMC: 2016 Oct 27.
Published in final edited form as: Anesthesiology. 2016 Jun;124(6):1265–1276. doi: 10.1097/ALN.0000000000001108

Table 6.

Agreement between Composite Assay (Combination of Survey and Automated Chart Review) and Manual Chart Review (N = 750)

Complication Frequency
Agreement
Combined Review Negative; Manual Review Negative Combined Review Negative; Manual Review Positive Combined Review Positive; Manual Review Negative Combined Review Positive; Manual Review Positive Positive Agreement (%) Negative Agreement (%) Kappa (95% CI)
Myocardial infarction 740 0 10 0 0 > 99
Cardiac arrest 744 0 6 0 0 > 99
Congestive heart failure 720 1 28 1 7 98 0.06 (−0.06 to 0.18)
Arrhythmia 640 5 67 38 51 95 0.47 (0.37 to 0.57)
Angina 739 2 8 1 17 > 99 0.16 (−0.12 to 0.45)
Stroke 733 0 13 4 38 > 99 0.38 (0.11 to 0.64)
Deep venous thrombosis 728 2 15 5 37 99 0.36 (0.13 to 0.59)
Pulmonary embolism 735 0 12 3 33 > 99 0.33 (0.05 to 0.61)
Wound infection 698 7 43 2 7 97 0.06 (−0.04 to 0.15)
Respiratory arrest 743 0 7 0 0 100
Respiratory failure 728 0 20 2 17 99 0.16 (−0.03 to 0.36)
Pneumonia 715 0 31 4 21 98 0.20 (0.03 to 0.36)
Kidney failure requiring dialysis 733 0 15 2 21 99 0.21 (−0.04 to 0.45)
Nerve injury 682 6 56 6 16 96 0.14 (0.03 to 0.25)
Gastrointestinal bleed 726 1 22 1 8 98 0.08 (−0.07 to 0.22)
Peptic ulcer 742 1 7 0 0 > 99 0.00 (−0.01 to 0.00)
Severe pain > 1 day 462 97 112 79 43 82 0.25 (−0.17 to 0.32)
Severe nausea/vomiting > 1 day 526 79 52 93 59 89 0.48 (0.40 to 0.55)

Note that these 750 patients are a subset of the 1,578 patients shown in table 3. Kappa is undefined if either the composite assay or the manual chart review identifies zero cases of a particular complication.